Extracellular matrix scaffolds for cartilage and bone regeneration

Trends in Biotechnology

Volumn 31, Issue 3, 2013, Pages 169-176

  Benders, Kim E M ^a   Weeren, P René van ^b   Badylak, Stephen F ^c   Saris, Daniël B F ^a,d   Dhert, Wouter J A ^a,b   Malda, Jos ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST RECONSTRUCTIVE SURGERY; CLINICAL APPLICATION; DECELLULARIZED TISSUES; EXTRACELLULAR MATRICES; NATURAL BIOMATERIALS; OSTEOCHONDRAL REPAIRS; OSTEOCHONDRAL TISSUE ENGINEERING; REGENERATIVE MEDICINE;

CARTILAGE; DIGITAL STORAGE; HISTOLOGY; REPAIR; TISSUE;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; COLLAGEN; COLLAGEN TYPE 2; DODECYL SULFATE SODIUM; FIBRIN; FIBRIN GLUE; GELATIN; NUCLEASE; POLYCAPROLACTONE; POLYLACTIC ACID; TISSUE SCAFFOLD; TRITON X 100; TRYPSIN;

BIODEGRADABILITY; BONE REGENERATION; BREAST RECONSTRUCTION; CARDIOVASCULAR SURGERY; CARTILAGE; CARTILAGE CELL; CARTILAGE INJURY; CHONDROCYTE IMPLANTATION; CHONDROGENESIS; CHONDROPATHY; CROSS LINKING; EXTRACELLULAR MATRIX; FREEZE THAWING; GASTROINTESTINAL SURGERY; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION;

BONE REGENERATION; CARTILAGE; EXTRACELLULAR MATRIX; GUIDED TISSUE REGENERATION; REGENERATIVE MEDICINE; TISSUE SCAFFOLDS;

EID: 84875265038     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2012.12.004     Document Type: Review

References (73)

1. Orthoworld (2009-2010) The Orthopaedic Industry Annual Report, Orthoworld Inc.
2. Brittberg M. Autologous chondrocyte implantation - technique and long-term follow-up. Injury 2008, 39(Suppl. 1):S40-S49.
3. Zheng M.H., et al. Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessment. Tissue Eng. 2007, 13:737-746.
4. Hangody L., et al. Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice. Orthopedics 1998, 21:751-756.
5. Bugbee W., et al. Osteochondral allograft transplantation in the knee. J. Knee Surg. 2012, 25:109-116.
6. Bugbee W.D., Convery F.R. Osteochondral allograft transplantation. Clin. Sports Med. 1999, 18:67-75.
7. Steadman J.R., et al. Microfracture to treat full-thickness chondral defects: surgical technique, rehabilitation, and outcomes. J. Knee Surg. 2002, 15:170-176.
8. Vinatier C., et al. Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol. 2009, 27:307-314.
9. Tohyama H., et al. Atelocollagen-associated autologous chondrocyte implantation for the repair of chondral defects of the knee: a prospective multicenter clinical trial in Japan. J. Orthop. Sci. 2009, 14:579-588.
10. Shin H., et al. The mechanical properties and cytotoxicity of cell-laden double-network hydrogels based on photocrosslinkable gelatin and gellan gum biomacromolecules. Biomaterials 2012, 33:3143-3152.
11. Ahmed T.A., et al. Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute. Tissue Eng. Part A 2011, 17:323-335.
12. Jeong C.G., et al. Three-dimensional polycaprolactone scaffold-conjugated bone morphogenetic protein-2 promotes cartilage regeneration from primary chondrocytes in vitro and in vivo without accelerated endochondral ossification. J. Biomed. Mater. Res. A 2012, 100:2088-2096.
13. Oshima Y., et al. Variation of mesenchymal cells in polylactic acid scaffold in an osteochondral repair model. Tissue Eng. Part C: Methods 2009, 15:595-604.
14. Badylak S.F., et al. Engineered whole organs and complex tissues. Lancet 2012, 379:943-952.
15. Nelson C.M., Bissell M.J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 2006, 22:287-309.
16. D'Onofrio A., et al. Clinical and hemodynamic outcomes after aortic valve replacement with stented and stentless pericardial xenografts: a propensity-matched analysis. J. Heart Valve Dis. 2011, 20:319-325. discussion 326.
17. Macchiarini P., et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008, 372:2023-2030.
18. Ricchetti E.T., et al. Scaffold devices for rotator cuff repair. J. Shoulder Elbow Surg. 2012, 21:251-265.
19. Martinello T., et al. Successful recellularization of human tendon scaffolds using adipose-derived mesenchymal stem cells and collagen gel. J. Tissue Eng. Regen. Med. 2012, 10.1002/term.1557.
20. Meyer T., et al. A new biocompatible material (Lyoplant) for the therapy of congenital abdominal wall defects: first experimental results in rats. Pediatr. Surg. Int. 2006, 22:369-374.
21. Armitage S., et al. Use of surgisis for treatment of anterior and posterior vaginal prolapse. Obstet. Gynecol. Int. 2012, 2012:376251.
22. Badylak S.F. The extracellular matrix as a biologic scaffold material. Biomaterials 2007, 28:3587-3593.
23. Tottey S., et al. The effect of source animal age upon extracellular matrix scaffold properties. Biomaterials 2012, 32:128-136.
24. Gilbert T.W. Strategies for tissue and organ decellularization. J. Cell. Biochem. 2012, 113:2217-2222.
25. Gong J., et al. Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors. Exp. Eye Res. 2008, 86:957-965.
26. Sellaro T.L., et al. Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng. 2007, 13:2301-2310.
27. Pei M., et al. A review of decellularized stem cell matrix: a novel cell expansion system for cartilage tissue engineering. Eur. Cell Mater. 2011, 22:333-343. discussion 343.
28. Vorotnikova E., et al. Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo. Matrix Biol. 2010, 29:690-700.
29. Martel-Pelletier J., et al. Cartilage in normal and osteoarthritis conditions. Best Pract. Res. Clin. Rheumatol. 2008, 22:351-384.
30. Engler A.J., et al. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
31. Turner N.J., et al. Xenogeneic extracellular matrix as an inductive scaffold for regeneration of a functioning musculotendinous junction. Tissue Eng. Part A 2010, 16:3309-3317.
32. Turner N.J., et al. Biologic scaffold remodeling in a dog model of complex musculoskeletal injury. J. Surg. Res. 2012, 176:490-502.
33. Penolazzi L., et al. Human mesenchymal stem cells seeded on extracellular matrix-scaffold: viability and osteogenic potential. J. Cell. Physiol. 2012, 227:857-866.
34. Badylak S.F. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl. Immunol. 2004, 12:367-377.
35. Schwarz S., et al. Processed xenogenic cartilage as innovative biomatrix for cartilage tissue engineering: effects on chondrocyte differentiation and function. J. Tissue Eng. Regen. Med. 2012, 10.1002/term.1650.
36. Crapo P.M., et al. An overview of tissue and whole organ decellularization processes. Biomaterials 2011, 32:3233-3243.
37. Chun S.Y., et al. Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials 2007, 28:4251-4256.
38. Han E., et al. Contribution of proteoglycan osmotic swelling pressure to the compressive properties of articular cartilage. Biophys. J. 2011, 101:916-924.
39. Keane T.J., et al. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 2012, 33:1771-1781.
40. Voytik-Harbin S.L., et al. Identification of extractable growth factors from small intestinal submucosa. J. Cell. Biochem. 1997, 67:478-491.
41. Badylak S.F., et al. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng. Part A 2008, 14:1835-1842.
42. Cole B.J., et al. Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up. Am. J. Sports Med. 2011, 39:1170-1179.
43. Chen C.C., et al. Cartilage fragments from osteoarthritic knee promote chondrogenesis of mesenchymal stem cells without exogenous growth factor induction. J. Orthop. Res. 2012, 30:393-400.
44. Ghanavi P., et al. The rationale for using microscopic units of a donor matrix in cartilage defect repair. Cell Tissue Res. 2012, 347:643-648.
45. Peretti G.M., et al. Tissue engineered cartilage integration to live and devitalized cartilage: a study by reflectance mode confocal microscopy and standard histology. Connect. Tissue Res. 2006, 47:190-199.
46. Elder B.D., et al. Extraction techniques for the decellularization of tissue engineered articular cartilage constructs. Biomaterials 2009, 30:3749-3756.
47. Schwarz S., et al. Decellularized cartilage matrix as a novel biomatrix for cartilage tissue-engineering applications. Tissue Eng. Part A 2012, 18:2195-2209.
48. Yang Q., et al. A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo cartilage tissue engineering with PKH26-labeled chondrogenic bone marrow-derived mesenchymal stem cells. Biomaterials 2008, 29:2378-2387.
49. Yang Z., et al. Fabrication and repair of cartilage defects with a novel acellular cartilage matrix scaffold. Tissue Eng. Part C: Methods 2010, 16:865-876.
50. Lu H., et al. Cultured cell-derived extracellular matrix scaffolds for tissue engineering. Biomaterials 2011, 32:9658-9666.
51. Lu H., et al. Autologous extracellular matrix scaffolds for tissue engineering. Biomaterials 2011, 32:2489-2499.
52. Gong Y.Y., et al. A sandwich model for engineering cartilage with acellular cartilage sheets and chondrocytes. Biomaterials 2011, 32:2265-2273.
53. Xue J.X., et al. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells induced by acellular cartilage sheets. Biomaterials 2012, 33:5832-5840.
54. Bank R.A., et al. Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage. Biochem. J. 1998, 330:345-351.
55. Jia S., et al. Oriented cartilage extracellular matrix-derived scaffold for cartilage tissue engineering. J. Biosci. Bioeng. 2012, 113:647-653.
56. Gerhardt L.C., et al. Neocellularization and neovascularization of nanosized bioactive glass-coated decellularized trabecular bone scaffolds. J. Biomed. Mater. Res. A 2012, 10.1002/jbm.a.34373.
57. Yang Q., et al. Evaluation of an extracellular matrix-derived acellular biphasic scaffold/cell construct in the repair of a large articular high-load-bearing osteochondral defect in a canine model. Chin. Med. J. (Engl.) 2011, 124:3930-3938.
58. Sadr N., et al. Enhancing the biological performance of synthetic polymeric materials by decoration with engineered, decellularized extracellular matrix. Biomaterials 2012, 33:5085-5093.
59. Kang Y., et al. Creation of bony microenvironment with CaP and cell-derived ECM to enhance human bone-marrow MSC behavior and delivery of BMP-2. Biomaterials 2011, 32:6119-6130.
60. Thibault R.A., et al. Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements. Tissue Eng. Part A 2010, 16:431-440.
61. Klein T.J., et al. Tissue engineering of articular cartilage with biomimetic zones. Tissue Eng. Part B: Rev. 2009, 15:143-157.
62. Malda J., et al. Comparative study of depth-dependent characteristics of equine and human osteochondral tissue from the medial and lateral femoral condyles. Osteoarthritis Cartilage 2012, 20:1147-1151.
63. Klein T.J., et al. Strategies for zonal cartilage repair using hydrogels. Macromol. Biosci. 2009, 9:1049-1058.
64. Schuurman W., et al. Bioprinting of hybrid tissue constructs with tailorable mechanical properties. Biofabrication 2011, 3:021001.
65. Khalil S., Sun W. Bioprinting endothelial cells with alginate for 3D tissue constructs. J. Biomech. Eng. 2009, 131:111002.
66. Padalino M.A., et al. Extracellular matrix graft for vascular reconstructive surgery: evidence of autologous regeneration of the neoaorta in a murine model. Eur. J. Cardiothorac. Surg. 2012, 42:e128-e135.
67. Geoffrion R., et al. Vaginal paravaginal repair with porcine small intestine submucosa: midterm outcomes. Female Pelvic Med. Reconstr. Surg. 2011, 17:174-179.
68. Yuan H., et al. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:13614-13619.
69. Jin C.Z., et al. In vivo cartilage tissue engineering using a cell-derived extracellular matrix scaffold. Artif. Organs 2007, 31:183-192.
70. Revell C.M., Athanasiou K.A. Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects. Tissue Eng. Part B: Rev. 2009, 15:1-15.
71. Guilak F. Biomechanical factors in osteoarthritis. Best Pract. Res. Clin. Rheumatol. 2011, 25:815-823.
72. Kheir E., et al. Development and characterization of an acellular porcine cartilage bone matrix for use in tissue engineering. J. Biomed. Mater. Res. A 2011, 99:283-294.
73. Badylak S.F., et al. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 2009, 5:1-13.